REACTION

27 Aug 2024 | Unclassified

REACTION Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk. Pediatric B-cell precursor acute lymphoblastic leukemia outcomes and survival have improved in the last decades, but unmet medical needs remain for this complex disease state and...

THERAVLINFO

22 May 2024 | Unclassified

THERAVLINFO – Transpyrenean network of advanced therapies in non-Hodgkin lymphoma THERAVLINFO is an advance in the biomedical translation of preclinical lymphoma knowledge and models generated in IMLINFO (EFA 281/16), in order to improve the survival and quality...

The NoLymiT team is principal investigator of the European THERAVLINFO project.

22 May 2024 | Participate, Participate NoLymiT, Unclassified

The NoLymiT team is principal investigator of the European THERAVLINFO project. THERAVLINFO is an advance in the biomedical translation of preclinical lymphoma knowledge and models generated in IMLINFO (EFA 281/16), in order to improve the survival and quality of life...

2nd Young Scientist Cancer Congress 2024 (YS2C)

15 Feb 2024 | Unclassified

2nd Young Scientist Cancer Congress 2024 (YS2C) New translational approaches in cancer therapy October 10 & 11, 2024 – Montpellier France The postdoc association of the Cancer Research Center of Toulouse was created in 2022 by Benoît Aliaga, Chloé Bessière...

3D-GATA2

18 Jan 2024 | Unclassified

3D-GATA2. Individuals with heterozygous germline GATA2 mutation present with a rare and highly heterogeneous syndrome. Prognosis is dismal, especially because of immunodeficiency and an exceedingly high risk of myelodysplastic syndrome and leukemia. While most...

1st Young Scientist Cancer Congress (YS2C)

21 Apr 2023 | Unclassified

1st Young Scientist Cancer Congress (YS2C) New research strategies for cancer therapy – from bench to bedside October 05, 2023 – Toulouse France The CRCT postdocs association was created in 2022 by Benoît Aliaga, Chloé Bessière and Steffen Fuchs. It gathers the...